Kaufman Rossin Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$572K Buy
495
+230
+87% +$271K 0.23% 47
2026
Q2
$322K Buy
265
+32
+14% +$32.7K 0.15% 73
2026
Q1
$214K Buy
233
+41
+21% +$41.6K 0.12% 93
2025
Q4
$206K Buy
+192
New +$184K 0.11% 152
2025
Q2
– Sell
-293
Closed -$242K – 173
2025
Q1
$242K Buy
+293
New +$244K 0.17% 115

Other funds holding LLY

Kaufman Rossin Wealth's LLY Position: Q3 2026 in Review

Kaufman Rossin Wealth increased its Eli Lilly (LLY) stake by 87% in Q3 2026, buying an estimated $271K and bringing the position to 495 shares worth $572K. The position accounts for 0.23% of the portfolio, ranked #47.

Kaufman Rossin Wealth first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. 3,679 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Kaufman Rossin Wealth held 495 shares of Eli Lilly worth $572K as of Q3 2026.
  • Kaufman Rossin Wealth bought 230 Eli Lilly shares in Q3 2026, an estimated $271K.
  • Eli Lilly made up 0.23% of Kaufman Rossin Wealth's portfolio in Q3 2026, its #47 holding.
  • Kaufman Rossin Wealth first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
  • 3,679 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Kaufman Rossin Wealth's 13F filing for Q3 2026, filed 19 Oct 2026.